Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant:  Evaluation of Healthcare Resource Utilization in the Aethera Trial

V. Bonthapally; E. Ma; S. Viviani; J. Radford; P. Brice; B. von Tresckow; E. Thomas; J. Teasell; A. Gnanasakthy; D. Odom; Y. Zhu; S. -Y. Lee; P. Carlson; D. Huebner; J. Sweetenham; C. Moskowitz; J. Walewski

Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial

V. Bonthapally, E. Ma, S. Viviani, J. Radford, P. Brice, B. von Tresckow, E. Thomas, J. Teasell, A. Gnanasakthy, D. Odom, Y. Zhu, S. -Y. Lee, P. Carlson, D. Huebner, J. Sweetenham, C. Moskowitz, J. Walewski

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	579-580
Number of pages	2
Journal	Haematologica
Volume	100
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Bonthapally, V., Ma, E., Viviani, S., Radford, J., Brice, P., von Tresckow, B., Thomas, E., Teasell, J., Gnanasakthy, A., Odom, D., Zhu, Y., Lee, S. .-Y., Carlson, P., Huebner, D., Sweetenham, J., Moskowitz, C., & Walewski, J. (2015). Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial. Haematologica, 100, 579-580.

@article{90d933213f364e63939ab8786d0cd87b,

title = "Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial",

author = "V. Bonthapally and E. Ma and S. Viviani and J. Radford and P. Brice and {von Tresckow}, B. and E. Thomas and J. Teasell and A. Gnanasakthy and D. Odom and Y. Zhu and Lee, {S. -Y.} and P. Carlson and D. Huebner and J. Sweetenham and C. Moskowitz and J. Walewski",

year = "2015",

language = "Undefined",

volume = "100",

pages = "579--580",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

}

Bonthapally, V, Ma, E, Viviani, S, Radford, J, Brice, P, von Tresckow, B, Thomas, E, Teasell, J, Gnanasakthy, A, Odom, D, Zhu, Y, Lee, S-Y, Carlson, P, Huebner, D, Sweetenham, J, Moskowitz, C & Walewski, J 2015, 'Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial', Haematologica, vol. 100, pp. 579-580.

TY - JOUR

T1 - Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant

T2 - Evaluation of Healthcare Resource Utilization in the Aethera Trial

AU - Bonthapally, V.

AU - Ma, E.

AU - Viviani, S.

AU - Radford, J.

AU - Brice, P.

AU - von Tresckow, B.

AU - Thomas, E.

AU - Teasell, J.

AU - Gnanasakthy, A.

AU - Odom, D.

AU - Zhu, Y.

AU - Lee, S. -Y.

AU - Carlson, P.

AU - Huebner, D.

AU - Sweetenham, J.

AU - Moskowitz, C.

AU - Walewski, J.

PY - 2015

Y1 - 2015

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000361204903431&KeyUID=WOS:000361204903431

M3 - Article

SN - 0390-6078

VL - 100

SP - 579

EP - 580

JO - Haematologica

JF - Haematologica

ER -

Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial

UN SDGs

Other files and links

Cite this